Safety, Toxicity, and Regulation in Use of Medicinal Plants

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27360%2F25%3A10260687" target="_blank" >RIV/61989100:27360/25:10260687 - isvavai.cz</a>

Výsledek na webu

<a href="https://link.springer.com/book/10.1007/978-3-032-01356-9" target="_blank" >https://link.springer.com/book/10.1007/978-3-032-01356-9</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-3-032-01356-9_2" target="_blank" >10.1007/978-3-032-01356-9_2</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Safety, Toxicity, and Regulation in Use of Medicinal Plants

Popis výsledku v původním jazyce

Medicinal plants contain various bioactive compounds that are significant in both traditional and contemporary therapeutic approaches, addressing a wide array of diseases. In addition to the benefits and historical application of herbal medicines, significant issues regarding safety, toxicity, and regulatory frameworks related to medicinal herbs exist. This chapter assesses the critical factors affecting the safe utilization of medicinal plants, encompassing potential adverse effects, challenges related to standardization and quality control, and regulatory obstacles across different global regions. Alkaloids, glycosides, tannins, and heavy metals are substances that raise toxicological concerns due to their potential to damage vital organs, disrupt cellular functions, or induce cancer when ingested in excessive amounts or over prolonged durations. Additionally, environmental factors, such as soil quality, climate, and toxin exposure significantly influence the toxicity levels of plants. This chapter emphasizes the importance of recent scientific advancements, such as metabolomics, genomics, and analytical chemistry, in developing standardized methods for the identification and quantification of bioactive constituents in medicinal plants. Moreover, studies grounded in evidence regarding the pharmacokinetics, pharmacodynamics, and toxicity of medicinal plants are crucial for the revision and enhancement of regulatory standards. The use of medicinal plants in healthcare systems offers numerous advantages; however, stringent safety and regulatory measures are essential to safeguard patient health. This chapter emphasizes the necessity of a comprehensive strategy that integrates stringent regulatory measures with scientific research to facilitate safe therapeutic applications while safeguarding public health. © 2025 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.

Název v anglickém jazyce

Safety, Toxicity, and Regulation in Use of Medicinal Plants

Popis výsledku anglicky

Medicinal plants contain various bioactive compounds that are significant in both traditional and contemporary therapeutic approaches, addressing a wide array of diseases. In addition to the benefits and historical application of herbal medicines, significant issues regarding safety, toxicity, and regulatory frameworks related to medicinal herbs exist. This chapter assesses the critical factors affecting the safe utilization of medicinal plants, encompassing potential adverse effects, challenges related to standardization and quality control, and regulatory obstacles across different global regions. Alkaloids, glycosides, tannins, and heavy metals are substances that raise toxicological concerns due to their potential to damage vital organs, disrupt cellular functions, or induce cancer when ingested in excessive amounts or over prolonged durations. Additionally, environmental factors, such as soil quality, climate, and toxin exposure significantly influence the toxicity levels of plants. This chapter emphasizes the importance of recent scientific advancements, such as metabolomics, genomics, and analytical chemistry, in developing standardized methods for the identification and quantification of bioactive constituents in medicinal plants. Moreover, studies grounded in evidence regarding the pharmacokinetics, pharmacodynamics, and toxicity of medicinal plants are crucial for the revision and enhancement of regulatory standards. The use of medicinal plants in healthcare systems offers numerous advantages; however, stringent safety and regulatory measures are essential to safeguard patient health. This chapter emphasizes the necessity of a comprehensive strategy that integrates stringent regulatory measures with scientific research to facilitate safe therapeutic applications while safeguarding public health. © 2025 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG.

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

10700 - Other natural sciences

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Medicinal Plants and Their Bioactives in Human Diseases

ISBN

978-3-032-01356-9

Počet stran výsledku

17

Strana od-do

41-57

Počet stran knihy

483

Název nakladatele

Springer Science+Business Media

Místo vydání

Germany

Kód UT WoS kapitoly

—